Denali Therapeutics Inc. (DNLI)
20.84
2.10 (11.21%)
At close: Jan 15, 2025, 12:55 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Net Income | -145.22M | -325.99M | -290.58M | 71.14M | -197.61M | -36.24M | -88.19M | -86.65M | -16.79M |
| Depreciation & Amortization | 16.73M | 10.38M | 8.59M | 8.53M | 7.99M | 7.42M | 3.08M | 1.47M | 121.00K |
| Stock-Based Compensation | 108.10M | 99.85M | 85.25M | 50.35M | 38.38M | 18.79M | 4.41M | 2.95M | 479.00K |
| Other Working Capital | -292.36M | -26.30M | -24.12M | 290.02M | 3.14M | 63.42M | 3.10M | 4.13M | -1.25M |
| Other Non-Cash Items | -47.67M | -4.92M | -2.98M | -2.32M | 513.00K | -2.74M | 754.00K | 5.28M | 710.00K |
| Deferred Income Tax | n/a | n/a | 8.75M | 55.00K | -5.02M | n/a | n/a | 307.00K | n/a |
| Change in Working Capital | -289.93M | -24.03M | -20.41M | 288.40M | 4.17M | 62.89M | 3.31M | 4.29M | 426.00K |
| Operating Cash Flow | -357.99M | -244.72M | -211.39M | 416.15M | -151.58M | 50.12M | -76.64M | -72.36M | -15.05M |
| Capital Expenditures | -12.94M | -17.83M | -8.50M | -3.10M | -17.92M | -3.39M | -2.88M | -6.13M | -3.06M |
| Acquisitions | n/a | 123.55M | 13.13M | 620.11M | -165.63M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -1.81B | -1.12B | -1.42B | -1.29B | -369.70M | -557.93M | -179.79M | -226.87M | n/a |
| Sales Maturities Of Investments | 2.08B | 991.49M | 1.41B | 665.36M | 535.33M | 273.90M | 141.50M | 14.00M | n/a |
| Other Investing Acitivies | n/a | -123.55M | -13.13M | -620.11M | 165.63M | -284.03M | -38.29M | -212.87M | n/a |
| Investing Cash Flow | 249.31M | -141.39M | -21.63M | -623.21M | 147.71M | -287.42M | -41.17M | -219.00M | -3.06M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.00M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 17.82M | 14.46M | 19.35M | 20.66M | 6.19M | 2.61M | 30.70M | 300.48M | 43.74M |
| Financial Cash Flow | 17.82M | 310.67M | 19.35M | 634.75M | 6.19M | 97.02M | 296.32M | 300.48M | 48.85M |
| Net Cash Flow | -90.86M | -75.43M | -213.67M | 427.69M | 2.33M | -140.29M | 178.52M | 9.11M | 30.74M |
| Free Cash Flow | -370.93M | -262.55M | -219.89M | 413.06M | -169.50M | 46.72M | -79.51M | -78.49M | -18.11M |